UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 162 filers reported holding UNIQURE NV in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $375 | -99.9% | 15,000 | -59.1% | 0.00% | -100.0% |
| Q1 2023 | $498,820 | -72.2% | 36,678 | -53.7% | 0.06% | -76.8% |
| Q4 2022 | $1,796,620 | +41.1% | 79,251 | +16.7% | 0.27% | +132.2% |
| Q3 2022 | $1,273,000 | +32.1% | 67,881 | +30.1% | 0.12% | +7.5% |
| Q2 2022 | $964,000 | -2.1% | 52,192 | -4.3% | 0.11% | +18.9% |
| Q1 2022 | $985,000 | +112.3% | 54,523 | +275.9% | 0.09% | +95.7% |
| Q3 2021 | $464,000 | -50.4% | 14,505 | -52.2% | 0.05% | -22.0% |
| Q2 2021 | $935,000 | -9.7% | 30,361 | -1.3% | 0.06% | +22.9% |
| Q1 2021 | $1,036,000 | -51.9% | 30,761 | -71.9% | 0.05% | -61.6% |
| Q4 2020 | $2,152,000 | -45.0% | 109,467 | -43.0% | 0.12% | -50.0% |
| Q3 2020 | $3,914,000 | – | 191,979 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |